Adult Vaccines Market - by Vaccine (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal

Vaccines refer to the biological preparation that improves immunity to fight against a particular disease. Vaccines comprise suspensions formulated from weakened, killed or fragmented microorganisms, toxins or antibodies that are administered to a patient, with a primary intention to prevent a disease. Vaccines offer active immunity against specific harmful and disease causing agents by stimulating the immune system to attack the agent. Vaccines helps to protect individuals against serious and fatal diseases such as influenza and measles among others. Adult immunization that includes administration of licensed vaccine provided to patients aged 18 years and older, for medical indications. Vaccines are routinely administered to eliminate the infectious diseases among infants and children, however the Centers of Disease Control & Prevention (CDC), 2016, also recommends adults to periodically take up vaccination, referred to as adult vaccines. According to the CDC 2015, 30% of the patients from mission Healthy People 2020 opted for Shingles vaccine and were reported to be safe from preventable illness.

The global Adult Vaccines Market was valued at US$ 12,806.49 million in 2017 and is expected to witness a robust CAGR of 7.1% over the forecast period (2017 - 2025).

Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1091

Among region, the market in North America held a dominant position in the global adult vaccines market in 2016. This is attributed to increasing investments facilitated by government as well as the manufacturers consistently focusing on promoting immunization in the U.S. For instance, in 2015, The Centers for Medicare & Medicaid Services (CMS), in alignment with the Centers for Disease Control and Prevention (CDC) introduced a five-year initiative named Healthy People 2020, to improve adult immunization as well as reduce the disparity rates caused majorly due to pneumonia, shingles, and influenza by working directly with physicians and provider offices, as well as with home health agencies, hospitals, beneficiaries and others under the guidance of Health Service Advisory Group (HSAG). Moreover, favorable Medicare coverage for adult vaccination in the U.S. also poses as a key factor favoring growth of the adult vaccines market. For instance, National Health Interview Survey (NHIS), 2015, reports an increase of 2.8% increased risk for pneumococcal disease among adults aged 19-64 years. The market in Asia Pacific is expected to witness significant traction, owing to extensive research conducted by the local players to cater to the increasing prevalence of diseases for which vaccines have not been developed. For instance, in January 2018, Bharat Biotech, an India-based company, was awarded with prequalification from the World Health Organization to develop world’s first rotavirus vaccine ROTAVAC.

Market players are engaged in development vaccines to cater to diseases with high epidemic

Market players are increasingly focusing on developing vaccines that caters to diseases with highest probability of causing an epidemic. For instance, in February 2017, an India-based drug firm, Cipla, in collaboration with Serum Institute of India, introduced Hepatitis B vaccine for adults in the country. The disease affects chronically over 40 million people in the country, as per India’s Universal Immunization Programme. Moreover, Dynavax Technologies Corporation received FDA approval in 2018, for its two-dosed Hepatitis-B vaccine indicated for adults aged 18 years and older.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1091

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.